Copaxone and Balance disorder for Women aged 30-39 (a phase IV clinical study of FDA data)

Summary:

Balance disorder is found for women aged 30-39 who take Copaxone (glatiramer acetate). This study is created by eHealthMe based on reports of 4,326 women aged 30-39 from the FDA, and is updated regularly. The information that eHealthMe analyzes includes:

Time on Copaxone when people have Balance disorder
Top conditions
Top co-used drugs
Top other side effects

On Aug, 02, 2026

4,326 women aged 30-39 reported to have side effects when taking Copaxone.
Among them, 65 people (1.5%) have Balance disorder

What is Copaxone?

Copaxone has active ingredients of glatiramer acetate. It is often used in multiple sclerosis. eHealthMe is studying from 56,931 Copaxone users. Check the latest studies of Copaxone.

What is Balance disorder?

Balance disorder is found to be associated with 2,129 drugs and 2,309 conditions by eHealthMe. Check the latest studies of Balance disorder.

Number of reports submitted per year:

Could Copaxone cause Balance disorder in women aged 30-39?

Time on Copaxone when people have Balance disorder *

Severity of Balance disorder

n/a

How people recovered from Balance disorder

n/a

Top conditions involved for these people *:

You may use this to check any potential undetected conditions.

Gait Disturbance: 7 people, 10.77%
Neuralgia (pain in one or more nerves): 2 people, 3.08%
Migraine (headache): 2 people, 3.08%
Joint Pain: 2 people, 3.08%
Mood Swings (an extreme or rapid change in mood): 1 person, 1.54%
Epilepsy (common and diverse set of chronic neurological disorders characterized by seizures): 1 person, 1.54%
Breast Cancer Female: 1 person, 1.54%

Top co-used drugs for these people *:

You may use this to check any potential interacting drugs.

Top other side effects for these people *:

You may use this to check any potential undetected side effects.

Weakness: 15 people, 23.08%
Dizziness: 15 people, 23.08%
Gait Disturbance: 14 people, 21.54%
Fatigue (feeling of tiredness): 13 people, 20.00%
Headache (pain in head): 10 people, 15.38%
Visual Impairment: 10 people, 15.38%
Fall: 10 people, 15.38%
Pain: 9 people, 13.85%
Hypoaesthesia (reduced sense of touch or sensation): 8 people, 12.31%
Memory Loss: 8 people, 12.31%

* Approximation only. Some reports may have incomplete information.

Do you take Copaxone and have Balance disorder?

- Check whether Balance disorder is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Related publications that referenced our studies:

Michaud CJ, Bockheim HM, Nabeel M, Daum TE, "Diagnosis of Exclusion: A Case Report of Probable Glatiramer Acetate-Induced Eosinophilic Myocarditis", Case reports in neurological medicine, 2014 Jul .
Michaud CJ, Bockheim HM, Nabeel M, Daum TE, "Diagnosis of Exclusion: A Case Report of Probable Glatiramer Acetate-Induced Eosinophilic Myocarditis", Case reports in neurological medicine, 2014 Jul .

Related studies:

Copaxone and Balance disorder

How the study uses the data?

The study is based on (applicable) gender, age, glatiramer acetate (the active ingredients of Copaxone) and Copaxone (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.